DNA合成設備市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、最終用途、應用、地區和競爭格局分類，2021-2031年

全球 DNA 合成設備市場預計將從 2025 年的 2.6121 億美元大幅成長到 2031 年的 4.4487 億美元，複合年成長率達到 9.28%。

DNA合成儀是一種自動化平台，它透過可控的化學反應來建構用於基因組應用的特定DNA序列（寡核苷酸）。其發展的主要驅動力是藥物研發中對合成基因的激增需求，以及基因組技術在個人化醫療領域日益廣泛的應用。龐大的臨床研發管線為這一強勁成長動能提供了支撐，預計到2024年，全球將有超過4000種基因療法、細胞療法和RNA療法正在研發中，所有這些療法都需要精確的遺傳物質。

市場促進因素

基於酵素的DNA合成平台的出現是市場發展的驅動力，從根本上解決了傳統化學方法的技術限制。與使用危險試劑且在長序列定序準確性方面面臨挑戰的亞磷醯胺化學不同，酵素法利用模板非依賴性聚合酵素在水溶液中合成DNA。這項創新顯著提高了產生複雜、高純度序列的能力，並克服了主要的規模化障礙。安莎生物技術公司（Ansa Biotechnologies）能夠生產長度達50 kb的DNA構建體就是一個典型的例子。同時，合成生物學生態系的快速發展也發揮著重要的催化作用，推動著對大規模基因合成的持續需求。生物製藥和工業生技公司擴大將遺傳物質的生產外包，這一趨勢得到了強勁風險投資的支持，預計到2024年，創投將達到122億美元，並體現在Twist Bioscience等領先公司的收入成長中。

市場挑戰

全球DNA合成設備市場的主要障礙在於高精度合成長DNA序列的技術限制。隨著寡核苷酸鍊長的增加，化學錯誤不斷累積，需要嚴格且高成本的合成後純化製程。這項要求推高了營運成本，並顯著限制了生產效率。因此，對於許多對成本敏感的研究機構而言，複雜遺傳物質的生產在商業性不可行，而製造商也難以在不承擔巨額成本的情況下拓展業務。這種低效性直接阻礙了市場成長，加劇了巨額資本流入（例如2024年合成生物學領域122億美元的創投）與實際生產效率之間的差距。因此，投資回報有限，合成技術在工業規模應用上的廣泛普及也停滯不前。

市場趨勢

隨著去中心化桌面DNA列印平台的推出，市場結構正在迅速重塑。這使得研究機構能夠實現寡核苷酸生產的內部化。這一趨勢滿足了營運自主性和更快的設計-建造-測試週期等關鍵需求，使科學家能夠避免集中式服務供應商帶來的物流延誤和資料安全風險。這種轉變在旨在擴展本地合成能力的策略性資金籌措中得到了清晰的體現，例如Telesis Bio公司籌集了高達2,100萬美元的資金用於現場合成資金籌措。同時，DNA資料儲存解決方案的商業化正在創造一個與傳統治療工作流程截然不同的新型高容量垂直市場。隨著全球對存檔容量的需求超過了矽和磁帶的物理極限，業界正將目光轉向DNA，將其作為一種高密度、耐用的資訊儲存介質，而這需要專門的高通量合成基礎設施。這個新興領域正在吸引大量資本，例如Twist Bioscience的衍生公司Atlas Data Storage就籌集了1.55億美元的種子資金，用於DNA存檔技術的產業化。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球DNA合成設備市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型（台式DNA合成儀、大型DNA合成儀）
  • 依最終用途（醫院/臨床檢查室、學術/研究機構、製藥/生技公司）分類
  • 按應用領域（藥物發現/開發、基因工程、臨床診斷）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美DNA合成設備市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲DNA合成設備市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區DNA合成設備市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲DNA合成設備市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美DNA合成設備市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球DNA合成設備市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Danaher Corporation
• Twist Bioscience Corporation
• LGC Limited
• CSBio Co.
• K&A Labs GmbH
• DNA Script SAS
• OligoMaker ApS
• PolyGen GmbH
• Biolytic Lab Performance Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global DNA Synthesizer Market is projected to grow substantially from USD 261.21 Million in 2025 to USD 444.87 Million by 2031, achieving a 9.28% CAGR. DNA synthesizers, automated platforms constructing specific DNA sequences (oligonucleotides) for genomic applications through controlled chemical reactions, are primarily propelled by the burgeoning demand for synthetic genes in pharmaceutical development and the increasing application of genomic technologies in personalized medicine. This robust growth trajectory is underpinned by a significant clinical pipeline, with over 4,000 gene, cell, and RNA therapies in development globally in 2024, requiring precise genetic materials.

Market Driver

The emergence of enzymatic DNA synthesis platforms represents a transformative market driver, fundamentally addressing the technical limitations of traditional chemical methods. Unlike phosphoramidite-based chemistry, which uses hazardous reagents and struggles with sequence fidelity at longer lengths, enzymatic approaches utilize template-independent polymerases to construct DNA under aqueous conditions. This innovation significantly enhances the ability to produce complex, high-purity sequences, overcoming a major barrier to scalability, as exemplified by Ansa Biotechnologies' capability to produce DNA constructs up to 50 kb in length. Concurrently, the rapid expansion of the synthetic biology ecosystem acts as a primary catalyst, driving sustained demand for large-scale gene synthesis, with biopharmaceutical and industrial biotechnology companies increasingly outsourcing genetic material production, a trend supported by robust venture investment, which reached $12.2 billion in 2024, and reflected in the revenue growth of key players like Twist Bioscience.

Market Challenge

A primary impediment obstructing the Global DNA Synthesizer Market is the technical limitation associated with synthesizing long DNA sequences with high fidelity. As oligonucleotide chain lengths increase, the accumulation of chemical errors necessitates rigorous and expensive post-synthesis purification processes. This requirement inflates operational costs and severely restricts production throughput, rendering the generation of complex genetic materials commercially unviable for many cost-sensitive research institutions and making it difficult for manufacturers to scale operations without incurring prohibitive expenses. This inefficiency directly dampens market growth by widening the gap between substantial capital influx, such as the $12.2 billion venture investment in synthetic biology in 2024, and tangible output efficiency, thereby limiting the return on investments and stalling broader adoption of synthesizer technology in industrial-scale applications.

Market Trends

The market structure is rapidly being reshaped by the adoption of decentralized benchtop DNA printing platforms, which enable research facilities to internalize oligonucleotide production. This trend addresses the critical need for operational autonomy and faster design-build-test cycles, allowing scientists to bypass logistical delays and data security risks associated with centralized service providers, a shift evident in strategic financing aimed at scaling localized synthesis capabilities, such as Telesis Bio securing up to $21 million for its on-site synthesis solutions. Simultaneously, the commercialization of DNA data storage solutions is creating a novel, high-volume application vertical distinct from traditional therapeutic workflows. As global demand for archival capacity exceeds the physical limits of silicon and magnetic tape, the industry is pivoting toward DNA as a dense, durable medium for information preservation, necessitating specialized high-throughput synthesis infrastructure. This emerging sector is attracting significant capital, highlighted by Twist Bioscience's spin-out of Atlas Data Storage, which raised $155 million in seed funding to industrialize DNA-based archival technologies.

Key Market Players

• Danaher Corporation
• Twist Bioscience Corporation
• LGC Limited
• CSBio Co.
• K&A Labs GmbH
• DNA Script SAS
• OligoMaker ApS
• PolyGen GmbH
• Biolytic Lab Performance Inc.

Report Scope

In this report, the Global DNA Synthesizer Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

DNA Synthesizer Market, By Type

• Benchtop DNA Synthesizers
• Large-scale DNA Synthesizers

DNA Synthesizer Market, By End use

• Hospitals & Clinical Laboratories
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies

DNA Synthesizer Market, By Application

• Drug Discovery & Development
• Genetic Engineering
• Clinical Diagnostics

DNA Synthesizer Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global DNA Synthesizer Market.

Available Customizations:

Global DNA Synthesizer Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global DNA Synthesizer Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Benchtop DNA Synthesizers, Large-scale DNA Synthesizers)
  • 5.2.2. By End use (Hospitals & Clinical Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies)
  • 5.2.3. By Application (Drug Discovery & Development, Genetic Engineering, Clinical Diagnostics)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America DNA Synthesizer Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End use
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States DNA Synthesizer Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End use
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada DNA Synthesizer Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End use
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico DNA Synthesizer Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End use
      • 6.3.3.2.3. By Application

7. Europe DNA Synthesizer Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End use
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany DNA Synthesizer Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End use
      • 7.3.1.2.3. By Application
  • 7.3.2. France DNA Synthesizer Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End use
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom DNA Synthesizer Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End use
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy DNA Synthesizer Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End use
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain DNA Synthesizer Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End use
      • 7.3.5.2.3. By Application

8. Asia Pacific DNA Synthesizer Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End use
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China DNA Synthesizer Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End use
      • 8.3.1.2.3. By Application
  • 8.3.2. India DNA Synthesizer Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End use
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan DNA Synthesizer Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End use
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea DNA Synthesizer Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End use
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia DNA Synthesizer Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End use
      • 8.3.5.2.3. By Application

9. Middle East & Africa DNA Synthesizer Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End use
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia DNA Synthesizer Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End use
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE DNA Synthesizer Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End use
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa DNA Synthesizer Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End use
      • 9.3.3.2.3. By Application

10. South America DNA Synthesizer Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End use
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil DNA Synthesizer Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End use
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia DNA Synthesizer Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End use
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina DNA Synthesizer Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End use
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global DNA Synthesizer Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Danaher Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Twist Bioscience Corporation
• 15.3. LGC Limited
• 15.4. CSBio Co.
• 15.5. K&A Labs GmbH
• 15.6. DNA Script SAS
• 15.7. OligoMaker ApS
• 15.8. PolyGen GmbH
• 15.9. Biolytic Lab Performance Inc.

16. Strategic Recommendations

17. About Us & Disclaimer